[1]
R. Percik, Y. Liel, D. Urban, J. Bar, E. Ben-Ami, and M. Abu Tailakh, “Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center database”, AO, vol. 60, no. 11, pp. 1466–1471, Nov. 2021.